299 related articles for article (PubMed ID: 24395243)
21. Molecular Features and Clinical Management of Hereditary Pancreatic Cancer Syndromes and Familial Pancreatic Cancer.
Kasuga A; Okamoto T; Udagawa S; Mori C; Mie T; Furukawa T; Yamada Y; Takeda T; Matsuyama M; Sasaki T; Ozaka M; Ueki A; Sasahira N
Int J Mol Sci; 2022 Jan; 23(3):. PubMed ID: 35163129
[TBL] [Abstract][Full Text] [Related]
22. Metastatic pancreatic adenocarcinoma associated with chronic calcific pancreatitis and a heterozygous SPINK1 N34S mutation.
Moran RA; Klapheke R; Jalaly NY; Makary MA; Hirose K; Goggins M; Wood L; Laheru DA; Lennon AM; Khashab MA; Singh VK
Pancreatology; 2016; 16(5):869-72. PubMed ID: 27358244
[TBL] [Abstract][Full Text] [Related]
23. Hereditary pancreatitis and familial pancreatic cancer.
Finch MD; Howes N; Ellis I; Mountford R; Sutton R; Raraty M; Neoptolemos JP
Digestion; 1997; 58(6):564-9. PubMed ID: 9438603
[TBL] [Abstract][Full Text] [Related]
24. Hereditary pancreatitis in children: surgical implications with special regard to genetic background.
Schmitt F; Le Henaff G; Piloquet H; Leclair MD; David A; Heloury Y; Podevin G
J Pediatr Surg; 2009 Nov; 44(11):2078-82. PubMed ID: 19944211
[TBL] [Abstract][Full Text] [Related]
25. Genetic predisposition and environmental risk factors to pancreatic cancer: A review of the literature.
Landi S
Mutat Res; 2009; 681(2-3):299-307. PubMed ID: 19150414
[TBL] [Abstract][Full Text] [Related]
26. Pancreatic carcinoma surveillance in patients with familial melanoma.
Parker JF; Florell SR; Alexander A; DiSario JA; Shami PJ; Leachman SA
Arch Dermatol; 2003 Aug; 139(8):1019-25. PubMed ID: 12925390
[TBL] [Abstract][Full Text] [Related]
27. CFTR, SPINK1, PRSS1, and CTRC mutations are not associated with pancreatic cancer in German patients.
Schubert S; Traub F; Brakensiek K; von Kopylow K; Marohn B; Maelzer M; Gaedcke J; Kreipe H; Stuhrmann M
Pancreas; 2014 Oct; 43(7):1078-82. PubMed ID: 25003218
[TBL] [Abstract][Full Text] [Related]
28. Identification of high-risk germline variants for the development of pancreatic cancer: Common characteristics and potential guidance to screening guidelines.
Bennett C; Suguitan M; Abad J; Chawla A
Pancreatology; 2022 Sep; 22(6):719-729. PubMed ID: 35798629
[TBL] [Abstract][Full Text] [Related]
29. Familial pancreatic cancer: Concept, management and issues.
Matsubayashi H; Takaori K; Morizane C; Maguchi H; Mizuma M; Takahashi H; Wada K; Hosoi H; Yachida S; Suzuki M; Usui R; Furukawa T; Furuse J; Sato T; Ueno M; Kiyozumi Y; Hijioka S; Mizuno N; Terashima T; Mizumoto M; Kodama Y; Torishima M; Kawaguchi T; Ashida R; Kitano M; Hanada K; Furukawa M; Kawabe K; Majima Y; Shimosegawa T
World J Gastroenterol; 2017 Feb; 23(6):935-948. PubMed ID: 28246467
[TBL] [Abstract][Full Text] [Related]
30. Familial pancreatic cancer.
Shi C; Hruban RH; Klein AP
Arch Pathol Lab Med; 2009 Mar; 133(3):365-74. PubMed ID: 19260742
[TBL] [Abstract][Full Text] [Related]
31. Double germline mutations in APC and BRCA2 in an individual with a pancreatic tumor.
Goehringer C; Sutter C; Kloor M; Gebert J; Slater EP; Keller M; Treiber I; Ganschow P; Kadmon M; Moog U
Fam Cancer; 2017 Apr; 16(2):303-309. PubMed ID: 27838800
[TBL] [Abstract][Full Text] [Related]
32. Mutation analysis of the PALB2 gene in unselected pancreatic cancer patients in the Czech Republic.
Borecka M; Zemankova P; Vocka M; Soucek P; Soukupova J; Kleiblova P; Sevcik J; Kleibl Z; Janatova M
Cancer Genet; 2016 May; 209(5):199-204. PubMed ID: 27106063
[TBL] [Abstract][Full Text] [Related]
33. Screening for Pancreatic Cancer in High-risk Populations.
Grover S; Jajoo K
Gastroenterol Clin North Am; 2016 Mar; 45(1):117-27. PubMed ID: 26895684
[TBL] [Abstract][Full Text] [Related]
34. AGA Clinical Practice Update on Pancreas Cancer Screening in High-Risk Individuals: Expert Review.
Aslanian HR; Lee JH; Canto MI
Gastroenterology; 2020 Jul; 159(1):358-362. PubMed ID: 32416142
[TBL] [Abstract][Full Text] [Related]
35. [Hereditary pancreatitis - a clinically relevant cause of pancreatic adenocarcinoma?].
Böttger T; Kirsch D; Hengstler JG; Bauer A; Wolf HK; Junginger T
Zentralbl Chir; 2001 Nov; 126(11):897-900. PubMed ID: 11753800
[TBL] [Abstract][Full Text] [Related]
36. Murine models for familial pancreatic cancer: Histopathology, latency and drug sensitivity among cancers of Palb2, Brca1 and Brca2 mutant mouse strains.
Park D; Shakya R; Koivisto C; Pitarresi JR; Szabolcs M; Kladney R; Hadjis A; Mace TA; Ludwig T
PLoS One; 2019; 14(12):e0226714. PubMed ID: 31877165
[TBL] [Abstract][Full Text] [Related]
37. Molecular pathology of primary and metastatic ductal pancreatic lesions: analyses of mutations and expression of the p53, mdm-2, and p21/WAF-1 genes in sporadic and familial lesions.
Ruggeri BA; Huang L; Berger D; Chang H; Klein-Szanto AJ; Goodrow T; Wood M; Obara T; Heath CW; Lynch H
Cancer; 1997 Feb; 79(4):700-16. PubMed ID: 9024708
[TBL] [Abstract][Full Text] [Related]
38. [Hereditary pancreatitis].
Simon P; Weiss FU; Mayerle J; Kraft M; Lerch MM
Praxis (Bern 1994); 2006 Oct; 95(42):1623-6. PubMed ID: 17111846
[TBL] [Abstract][Full Text] [Related]
39. The natural history of hereditary pancreatitis: a national series.
Rebours V; Boutron-Ruault MC; Schnee M; Férec C; Le Maréchal C; Hentic O; Maire F; Hammel P; Ruszniewski P; Lévy P
Gut; 2009 Jan; 58(1):97-103. PubMed ID: 18755888
[TBL] [Abstract][Full Text] [Related]
40. Familial pancreatic cancer and hereditary syndromes: screening strategy for high-risk individuals.
Matsubayashi H
J Gastroenterol; 2011 Nov; 46(11):1249-59. PubMed ID: 21847571
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
